title: Biomarkers for tyrosine kinase inhibitors in renal cell cancer.
authors.affiliation: 1 Department of Medical Oncology, Liverpool Hospital, NSW, Australia ; 2 University of Western Sydney School of Medicine CRG, NSW, Australia.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Coupe
authors.affiliation: 1 Department of Medical Oncology, Liverpool Hospital, NSW, Australia ; 2 University of Western Sydney School of Medicine CRG, NSW, Australia.
authors.forename: Michelle
authors.initials: M
authors.lastname: Harrison
authors.affiliation: 1 Department of Medical Oncology, Liverpool Hospital, NSW, Australia ; 2 University of Western Sydney School of Medicine CRG, NSW, Australia.
authors.forename: Wei
authors.initials: W
authors.lastname: Chua
authors.affiliation: 1 Department of Medical Oncology, Liverpool Hospital, NSW, Australia ; 2 University of Western Sydney School of Medicine CRG, NSW, Australia.
authors.forename: Paul
authors.initials: P
authors.lastname: de Souza
references.citation: Cancer Chemother Pharmacol. 2010 Jul;66(2):357-71
references.pmid: 19967539
references.citation: Eur J Cancer. 2011 Nov;47(17):2592-602
references.pmid: 21889330
references.citation: Clin Pharmacol Ther. 2001 Mar;69(3):89-95
references.pmid: 11240971
references.citation: Cancer Res. 2004 Oct 1;64(19):7099-109
references.pmid: 15466206
references.citation: Clin Cancer Res. 2010 Dec 15;16(24):5923-7
references.pmid: 21059813
references.citation: Transl Oncol. 2010 Feb;3(1):56-64
references.pmid: 20165696
references.citation: Clin Genitourin Cancer. 2007 Sep;5(6):379-85
references.pmid: 17956710
references.citation: N Engl J Med. 2007 Jan 11;356(2):185-7
references.pmid: 17215538
references.citation: N Engl J Med. 2007 Jan 11;356(2):115-24
references.pmid: 17215529
references.citation: Clin Cancer Res. 2010 Oct 1;16(19):4853-63
references.pmid: 20651059
references.citation: BMC Cancer. 2009 Mar 12;9:82
references.pmid: 19284623
references.citation: Br J Cancer. 2009 Dec 1;101(11):1876-83
references.pmid: 19904265
references.citation: Kidney Int. 2010 May;77(9):809-15
references.pmid: 20147887
references.citation: J Clin Oncol. 2004 Feb 1;22(3):454-63
references.pmid: 14752067
references.citation: J Clin Oncol. 2008 Oct 10;26(29):4708-13
references.pmid: 18541897
references.citation: Kidney Int. 2005 May;67(5):2069-82
references.pmid: 15840065
references.citation: J Transl Med. 2007 Jul 02;5:32
references.pmid: 17605814
references.citation: Invest New Drugs. 2012 Dec;30(6):2443-9
references.pmid: 22644070
references.citation: Cancer. 2012 Apr 1;118(7):1946-54
references.pmid: 21882181
references.citation: Clin Cancer Res. 2011 Feb 1;17 (3):620-9
references.pmid: 21097692
references.citation: Cancer. 2010 Sep 15;116(18):4256-65
references.pmid: 20549832
references.citation: Carcinogenesis. 2003 Nov;24(11):1779-83
references.pmid: 12919954
references.citation: J Clin Oncol. 2011 Jun 20;29(18):2459-65
references.pmid: 21555686
references.citation: Lancet Oncol. 2011 Nov;12 (12 ):1143-50
references.pmid: 22015057
references.citation: Angiogenesis. 2009;12 (1):69-79
references.pmid: 19212818
references.citation: Eur J Cancer. 2008 May;44(7):946-53
references.pmid: 18396036
references.citation: N Engl J Med. 2007 May 31;356(22):2271-81
references.pmid: 17538086
references.citation: J Clin Oncol. 2004 Jun 15;22(12):2371-8
references.pmid: 15197198
references.citation: J Clin Oncol. 1999 Aug;17(8):2530-40
references.pmid: 10561319
references.citation: Cancer Res. 2010 Feb 1;70(3):1063-71
references.pmid: 20103651
references.citation: Cancer. 2010 Jan 1;116(1):57-65
references.pmid: 19862815
references.citation: Clin Adv Hematol Oncol. 2012 May;10(5):307-14
references.pmid: 22706540
references.citation: J Natl Cancer Inst. 2006 Mar 1;98(5):326-34
references.pmid: 16507829
references.citation: Lancet. 2011 Dec 3;378(9807):1931-9
references.pmid: 22056247
references.citation: Lancet Oncol. 2012 Aug;13(8):827-37
references.pmid: 22759480
references.citation: J Clin Oncol. 2009 Jul 10;27(20):3312-8
references.pmid: 19451442
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: Cancer Sci. 2010 Apr;101(4):963-8
references.pmid: 20180805
references.citation: Clin Chem. 2008 Dec;54(12):e11-79
references.pmid: 19042984
references.citation: J Clin Oncol. 2012 Sep 20;30(27):3402-7
references.pmid: 22891270
references.citation: BMC Cancer. 2010 Dec 31;10 :695
references.pmid: 21194438
references.citation: Lancet. 2008 Aug 9;372(9637):449-56
references.pmid: 18653228
references.citation: J Clin Oncol. 2009 Aug 10;27(23):3836-41
references.pmid: 19597027
references.citation: Lancet Oncol. 2009 Aug;10 (8):757-63
references.pmid: 19615940
references.citation: J Clin Oncol. 2009 Sep 10;27(26):4406-12
references.pmid: 19667267
references.citation: Cancer. 2009 Aug 15;115(16):3651-60
references.pmid: 19526589
references.citation: J Clin Oncol. 2010 Feb 20;28(6):1061-8
references.pmid: 20100962
references.citation: J Urol. 2001 Nov;166(5):1611-23
references.pmid: 11586189
references.citation: Nat Rev Drug Discov. 2006 Oct;5(10):835-44
references.pmid: 17016424
references.citation: Int J Cancer. 1997 Jul 29;72(3):424-30
references.pmid: 9247285
references.citation: Clin Cancer Res. 2011 Aug 15;17 (16):5443-50
references.pmid: 21828239
references.citation: Clin Cancer Res. 2008 Nov 15;14(22):7272-83
references.pmid: 19010843
references.citation: Br J Cancer. 2011 Mar 29;104(7):1144-50
references.pmid: 21386843
references.citation: Target Oncol. 2010 Jun;5(2):85-94
references.pmid: 20582732
references.citation: J Clin Oncol. 2009 Aug 1;27(22):3584-90
references.pmid: 19487381
references.citation: J Clin Oncol. 2008 Aug 1;26(22):3743-8
references.pmid: 18669461
references.citation: J Clin Oncol. 2011 Jun 20;29(18):2557-64
references.pmid: 21576632